Showing results (141-150 of 190) with videos related to
Sort By:
Pageof 19
Acta Oncologica (Stockholm, Sweden)|July 17, 2012
Swedish Lung Cancer Radiation Study Group: predictive value of age at diagnosis for radiotherapy response in patients with non-small cell lung cancerGeorg Holgersson, Even Hoye, Michael Bergqvist, et al.Medical Oncology (Northwood, London, England)|December 21, 2012
The impact of hyperfractionated radiotherapy regimen in patients with non-small cell lung cancerGeorg Holgersson, Michael Bergqvist, Jan Nyman, et al.The New England Journal of Medicine|February 21, 2014
Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastomaOlivier L Chinot, Wolfgang Wick, Warren Mason, et al.Acta Oncologica (Stockholm, Sweden)|October 25, 2011
DNA-repair gene variants are associated with glioblastoma survivalCarl Wibom, Sara Sjöström, Roger Henriksson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosisQianren Jin, Kari Hemminki, Kerstin Enquist, et al.Journal of Neuro-Oncology|June 7, 2011
Analysis of DNA repair gene polymorphisms and survival in low-grade and anaplastic gliomasShala Ghaderi Berntsson, Carl Wibom, Sara Sjöström, et al.Oncotarget|September 15, 2016
PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation statusKenney R Roodakker, Tamador Elsir, Per-Henrik D Edqvist, et al.Journal of Neuro-Oncology|May 17, 2003
Boron neutron capture therapy for glioblastoma multiforme: clinical studies in SwedenJacek Capala, Britta H Stenstam, Kurt Sköld, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2026
Framework for statistical parametric mapping of the interactions between glioblastoma location, treatment, prognostic variables, and survival using a phase III trialFrancesco Sanvito, Catalina Raymond, Donatello Telesca, et al.Journal of Neuro-Oncology|July 17, 2022
Incidence, molecular characteristics, and imaging features of "clinically-defined pseudoprogression" in newly diagnosed glioblastoma treated with chemoradiationAkifumi Hagiwara, Jacob Schlossman, Soroush Shabani, et al.Pageof 19